Company

Company

 

Vision

Contribute to people’s health and future with our innovative products.

Message from Haruhiko Inufusa

For 25 years, I worked for Faculty of Medicine in Kinki University as a surgeon and a cancer researcher. Now, continuing research at the Antioxidant Division of Life Science Research Center and believing “to live longer with being healthy” is all human beings’ hope.

Today, it is clear that more than 150 kinds of diseases are closely related to oxidative stress. By reducing them, it is possible to prevent many diseases. However till now, there was no research evidence, which proves effective antioxidant without any side effects.

We aim preventing human diseases not with newly developed medicines for cancer and diabetes, but by products with correct medical evidence in reasonable price. Moreover, our products are expected to be effective to diseases that have no effective ways of medical treatments or have very limited medical therapy. We believe we can suggest them as a new treatment to many of those who suffer from those diseases.

We are going to develop our research further on alcohol metabolism, glycometabolism and lipid metabolism, and oxidative stress to provide right products in need for people all over the world.

 

Dr. Haruhiko Inufusa

Haruhiko Inufusa

  • Representative Director at TIMA Japan Corporation
  • Physician
  • Doctor of Medicine
  • Specially appointed professor at the antioxidant division of Life Science Research Center, Gifu University
  • Former professor at Kinki University
Educational
Background
1982 Graduated from Faculty of Medicine, Kinki University
1988 Graduated from Graduate School of Medical Sciences, Kinki University, majored in surgical medicin
1988～1990 Postdoctoral Fellow at the Dr. Senichiro Hakomori class, Division of Biochemistry, university of Washington Seattle, U. S. A.
Professional
Experience
1991～2000 Faculty of Medicine, Lecturer at Kinki University
2001～2003 Professor at Department of Clinical Laboratory Medicine／Clinical Nutrition, Faculty of Medicine, Kinki University
Apr.2004 ～
Oct. 2004		 Visiting Professor at European Tele-Surgery Research Institute, Strasbourg University
Nov. 2004 ～
Mar. 2005		 Visiting Professor at the Division of Surgery, The University of Barcelona, Spain
Apr. 2005 ～
Dec. 2006		 Head of Office at Advanced Medicine/Health Economics Management Office, Faculty of Medicine, Kinki University
2007～
Oct. 2013		 Representative Director at Brookfield Medical Corporation
2011 ～
Oct. 2013		 Representative Director at TIMA Japan Corporation
 

Company Information

SUPALIV
Established June 1, 2015
（※2006年12月1日創業）
Representative Representative Director and Chairman President　Sho Tanaka
Address

・Tokyo Head Office
〒150-0013　
3-15-2 Ebisu, Shibuya-ku, Tokyo SP15 EBISU 3F

・Osaka branch社
404-1-9-1 Minamisemba, Chuo-ku,
Osaka city 542-0081
Capital JPY 21 million
Major shareholders European Medical Foundation TIMA
Business description SUPALIV Manufacturing and sales
TIMA Tokyo
Established June 21, 2019
Representative Representative Director and Chairman　President　Sho Tanaka
Address

・Tokyo Head Office
〒150-0013　
3-15-2 Ebisu, Shibuya-ku, Tokyo SP15 EBISU 3F

・Osaka branch社
404-1-9-1 Minamisemba, Chuo-ku,
Osaka city 542-0081
Capital JPY 8 million
Major shareholders European Medical Foundation TIMA
Business description Twendee X Manufacturing and sales
TIMA establishment
Address Alte Churer Strasse 45 FL-9496 Balzers Liechtenstein
Director Markus Count Matuschka de Greiffenclau
Chief Researcher Haruhiko Inufusa
 

Board members, Special Counsel, and Ambassadors

TIMA establishment

Markus Count Matuschka de Greiffenclau

Chief Director at European Medical Foundation TIMA Foundation

Born in Germany. Since 1990, Providing investment and management consulting for companies such as Skype.
In 2005, established TIMA Stiftung Foundation to donate to the medical research.
Currently, managing following companies also.
「Lysando（http://www.lysando.com/）」
CEOーThe biochemical patent owned company such as antibacterial agents without drug resistance cause, etc. (Liechtenstein, Switzerland)
「Domaine Prive（www.cognac-cognac.com）」
Directorー Production and sales of wine and cognac (Cognac, France)

Haruhiko Inufusa

SUPALIV TIMA Tokyo

Sho Tanaka

Yohei Tsukamoto

Adviser
Toshikazu Yoshikawa

Toshikazu Yoshikawa

中島　拓

Taku Nakashima

Helmut Durchschlag

Helmut Durchschlag

Doctor at the Radiation physics study at University of Regensburg (Germany) http://www.researchgate.net/profile/Helmut_Durchschlag
Christian Amatore

Christian Amatore

Professor at the French Academy of Sciences（member of Institut de France）
Koji Fukui

Koji Fukui

 

History

January, 2001 Establishment of TIMA Stiftung Foundation
June, 2005 Markus Matuschka v.Greiffenclau appointed as Chief Director at TIMA Stiftung.
June, 2005 Haruhiko Inufusa appointed as Chief Researcher at TIMA Stiftung.
November, 2006 Establishment of Brookfield Medical Corporation.
November, 2010 Start of selling “SUPALIV”.
March, 2011 Start of selling the new package”SUPALIV” designed by Mr. Kazunari Hitagawa.
December, 2011 Establishment of TIMA Japan Corporation for sales purpose.
February, 2012 Brookfield Medical Corporation merged and acquired TIMA Japan Corporation and named the company TIMA Japan Corporation.
Start of selling “Oxicut”.
November, 2013 Developer Dr. Haruhiko Inufusa appointed to the Specially appointed professor of the Antioxidant Division, Life Science Research Center at Gifu University.
July, 2015 Establishment of SUPALIV Corporation for sales and marketing purposes.